Testing effectiveness (Phase 2)Study completedNCT01477879What this trial is testingHsv 1 and 2 Gowey Protocol Versus PlaceboWho this might be right forHerpes Naturopaths International 33
Large-scale testing (Phase 3)Study completedNCT00878072What this trial is testingSafety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes LabialisWho this might be right forHerpes Labialis Novartis Pharmaceuticals 53
Not applicableAvailableNCT05844436What this trial is testingExpanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2Who this might be right forHSV AiCuris Anti-infective Cures AG
Testing effectiveness (Phase 2)Study completedNCT00371592What this trial is testingEffectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)Who this might be right forHIV InfectionsHerpesvirus 2, Human National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Active Not RecruitingNCT06375512What this trial is testingDescribe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsWho this might be right forHerpes Zoster Shenzhen Shenxin Biotechnology Co., Ltd 150
Testing effectiveness (Phase 2)Looking for participantsNCT06569823What this trial is testingSafety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverWho this might be right forShinglesHerpes ZosterVaccine-Preventable Diseases Dynavax Technologies Corporation 764
Large-scale testing (Phase 3)Study completedNCT01574612What this trial is testingOpen Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years OldWho this might be right forHerpes Labialis Meda Pharmaceuticals 54
Early research (Phase 1)Ended earlyNCT04348916What this trial is testingStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsWho this might be right forCancerMelanomaSolid Tumor+7 more Oncorus, Inc. 66
Early research (Phase 1)Study completedNCT02852876What this trial is testingStudy to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of FoodWho this might be right forHerpes GenitalisHerpes Zoster Astellas Pharma Europe Ltd. 72
Early research (Phase 1)Study completedNCT00002116What this trial is testingA Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDSWho this might be right forHerpes SimplexHIV Infections Gilead Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00448227What this trial is testingPharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex InfectionWho this might be right forHerpes Simplex Novartis 18
Early research (Phase 1)Looking for participantsNCT03911388What this trial is testingHSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsWho this might be right forNeoplasms, BrainGlioblastoma MultiformeGlioblastoma of Cerebellum+30 more M.D. Anderson Cancer Center 24
Large-scale testing (Phase 3)Study completedNCT01386294What this trial is testingSafety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionWho this might be right forHIV Prevention CONRAD 2,059
Early research (Phase 1)Study completedNCT05871541What this trial is testingA First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccineWho this might be right forHerpes Zoster (HZ)ShinglesInfectious Disease Immorna Biotherapeutics, Inc. 75
Not applicableUnknownNCT01646411What this trial is testing300 Antibody Diagnostic Test KitWho this might be right forAcute Bacterial InfectionsAcute Viral Infections The Plasma Source 300
Early research (Phase 1)Study completedNCT03661541What this trial is testingImmune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)Who this might be right forHSVHerpes Labialis Squarex, LLC 36
Early research (Phase 1)Not Yet RecruitingNCT06954818What this trial is testingSafety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or MoreWho this might be right forHerpes Zoster CSPC Megalith Biopharmaceutical Co.,Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT06033261What this trial is testingMRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital HerpesWho this might be right forGenital Herpes ModernaTX, Inc. 365
Not applicableLooking for participantsNCT05198570What this trial is testingPharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric PatientsWho this might be right forHerpesviridae InfectionsHerpes Simplex 1Varicella Zoster Virus Infection+2 more University of Pisa 200
Not applicableWithdrawnNCT03421548What this trial is testingImplantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1Who this might be right forGlaucomaBlindness, AcquiredKeratitis, Herpetic+4 more Centre hospitalier de l'Université de Montréal (CHUM)